Search for: "Ives, A. v. Ives, K." Results 41 - 60 of 625
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Apr 2010, 7:20 am by Jim Gerl
(brainz.org)Council of Administrators of Special Education Endorses Curriculum Advantage's Classworks K-12 Instructional Software (eon.businesswire.com)Train to Gain is money well spent (guardian.co.uk)How do you train your new biotechnology employees? [read post]
30 Nov 2023, 9:01 pm by renholding
If it changes the peer group in subsequent years, it must provide disclosure of the change in accordance with Regulation S-K Item 402(v)(2)(iv). [read post]
25 May 2011, 4:59 am by Marie Louise
(Kluwer Patent Blog) USPTO statement at WIPO side event on Medicines Patent Pool (Knowledge Ecology International) US: To implement health reform orphan drug exclusion, HRSA issues first-ever proposed regulation on 340B drug discount program (FDA Law Blog) US: FDA officials hint at provisions of biosimilar guidances (Patent Docs) US: Huffington Post: Data Exclusivity: Getting the balance right (PatentlyBIOtech) US: Report gauges economic impact of Human Genome Project (Patent Docs) US: Chairman… [read post]
15 Dec 2010, 2:17 am by Kelly
General Coming soon: International Classification of traditional medicine by WHO (Spicy IP) Teva Pharma uses online game to promote generic substitution (Patent Baristas) Australia: APO: Success of phase 3 trials ‘obvious’ in view of phase 1 and 2: Genentec, Inc (Patentology) Brazil: Government support to impel Brazil generic market (GenericsWeb) EU: EPO Enlarged Board of Appeal decides Broccoli (G2/07) and Tomatoes (G1/08) – essentially biological breeding processes not patentable… [read post]
5 Jul 2015, 3:49 pm
(o) for the passing of accounts,(p) fixing and approving the remuneration of a personal representative, or(q) subject to subrule (2), respecting any other matter concerning(i)   an authorization to obtain estate information,(ii)   an authorization to obtain resealing information,(iii)   a grant of probate,(iv)   a grant of administration with or without will annexed,(v)   an ancillary grant,(vi)   a resealing, or(vii)   the office of personal… [read post]
20 Dec 2014, 4:40 pm by James Hamilton
Directs the SEC to adopt regulations allowing companies to include a summary page with Form 10-K and revising Regulation S-K to reduce the burden on smaller issuers, including emerging growth companies. [read post]
12 Mar 2024, 2:48 am by INFORRM
Under no circumstances,’ underlines judge Kūris in his elaborated dissenting opinion in Mesić v. [read post]
10 Jul 2023, 4:32 pm by Kurt R. Karst
Performance Metric FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 Average Number of FDA Days to MDUFA IV Decision 72.62 73.55 79.33 83.40 77.38 Average Number of Industry Days to MDUFA IV Decision 54.69 60.40 70.34 75.82 52.17 Average Number of Total Days to MDUFA IV Decision 127.31 133.95 149.67 159.22 129.55 Table 2. 510(k) Time to MDUFA IV Decision. [read post]
2 Oct 2016, 12:11 pm by Dennis Crouch
 Cir. 2016) is not that the court found IV’s content identification system patents invalid as claiming ineligible subject matter. [read post]
10 Feb 2010, 8:44 am by Tarunabh Khaitan
The Delhi High Court delivered a landmark judgment in the case of Manushi Sangathan v. [read post]
14 Apr 2022, 7:37 pm by Kurt R. Karst
  MDUFA V would be applicable to fiscal years 2023 through 2027. [read post]
8 Jan 2018, 12:28 pm by Dan Ernst
Sirks, 2014Laurent Waelkens  pp.: 629–631 (3)[Book Reviews] Postmortale Privatautonomie und Willensvollstreckung, Von der kanonischen voluntas pia zur Gestaltungsmacht des Erblassers im deutsch-spanischen Rechtsvergleich, written by Lena Kunz, 2015Jan Hallebeek  pp.: 632–633 (2)             Urkundenregesten zur Tätigkeit des deutschen Königs- und Hofgerichts bis 1451, Band 10: Die Zeit Karls IV.… [read post]